rich 1.0 Hosts Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, welcome Dana Rizk, MD, professor of medicine in the Division of Nephrology at the University of Alabama at Birmingham. Rizk walks through the 24-month eGFR and safety findings from the phase 3 VISIONARY trial of sibeprenlimab (Voyxact) in IgA nephropathy (IgAN) in the lastest episode of Kidney Compass. Kidney Compass: Navigating Clinical Trials https://audioboom.com/channels/5143641-kidney-compass-navigating-clinical-trials Audioboom https://audioboom.com 480 95 https://audioboom.com/i/43789120/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8939872/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>